Clobazam Tablet
Product Images NDC 16714-888

5 FDA label images from Northstar Rxllc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 16714-888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clobcontlabel10mg

Clobcontlabel10mg
Clobazam Tablets 10 mg oral tablets label with NDC 16714-887-01. The label indicates the tablet strength as 10 mg, the package count as 100 tablets, and includes storage instructions, manufacturer details (Hetero Labs Limited, India), and distributor information (NorthStar Rx LLC). It also includes a barcode and directions to dispense the Medication Guide separately to each patient.*
FDA Label Image

Clobcontlabel20mg

Clobcontlabel20mg
Label for Clobazam Tablets 20 mg, oral tablets, packaged in a container of 100 tablets. Label displays NDC 16714-888-01 and states the product is prescription only. Manufactured for NorthStar Rx LLC, Memphis, TN, with manufacturing by Hetero Labs Limited, India. Instructions on storage at 20°C to 25°C and pharmacist dispensing of Medication Guide included. Barcode and lot/issue date information present.*
FDA Label Image

Clobfig1

Clobfig1
Bar graph showing percentage reduction in weekly drop seizure rate comparing placebo and three dosage levels (Low, Medium, High) of clobazam tablets. The graph indicates increasing seizure rate reduction with higher clobazam doses, with placebo showing the least reduction. Sample sizes for each group range from 49 to 58.*
FDA Label Image

Clobfig2

Clobfig2
A bar chart displaying the proportion of patients (%) on the vertical axis versus reduction in weekly drop seizure frequency from baseline (%) on the horizontal axis. The chart compares four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High across different seizure reduction ranges, illustrating patient response to varying Clobazam dosages relative to placebo.*
FDA Label Image

Clobtabstructure

Clobtabstructure
Chemical structure of Clobazam, showing its molecular composition and arrangement typical of a benzodiazepine derivative. The diagram displays rings and functional groups including chlorine, methyl, and carbonyls clearly visible in the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.